Spero
spero.ai
Actively hiring
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Spero is a medical technology company headquartered in Moscow, Russia, that was established in 2019. The organization specializes in the development of the SPERO-screen, a diagnostic system that utilizes hormonal blood test results and patient data to predict fertility windows through proprietary mathematical algorithms. It operates across major Russian cities through partnerships with clinical laboratories and offers direct-to-consumer mobile testing services within the Moscow region.
News
Pangram dreams of a slop-free future.
Max Spero-a cofounder of Pangram, an AI detection tool popular among journalists-asks,
Read more
Report
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
Entered an exclusive license agreement with Innovent Biologics for SP001, a Phase 2-ready, third-generation anti-CD40L antibody for immune-mediate...
Read more
Report
Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.
Read more
Report
Max Spero (@max_spero_) on X
This is an important event: the first time AI-induced psychosis has affected a well-respected and high achieving individual. In this case, ChatGPT started spitting out SCP-style roleplay, and it seems like memory is playing a large part in ensuring the ha
Read more
Report
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
--Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant bacterial infections, today announced financial results for the fourth qu
Read more
Report
Spero Therapeutics: The Multi-Asset Pipeline Could Outpace The Tebipenem HBr Deal With GSK
Read more
Report
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
--Spero Therapeutics, Inc.- a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases- today ann
Read more
Report
All of us go through dark periods, esp. now in these trying times when it sometimes feels like hope is all we have left. But we keep grinding each day managing through the highs and lows. As… Ha Nguyen 18 comments
All of us go through dark periods, esp. now in these trying times when it sometimes feels like hope is all we have left. But we keep grinding each day managing through the highs and lows. As founders, we need to believe in ourselves beyond reason to build
Read more
Report
Show more news
Growth
Hiring Momentum
73/100
Growing
Open positions
2
1 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
100% ▲
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
Owatonna
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Moscow
Russia
HQ
Owatonna
United States
2 open roles 2 posted in 90 days
hires for Administrative